TABLE 2

Secondary Outcomes

Secondary OutcomesEFURCI (N = 104)Conventional (N = 103)Univariate Analysis, POR (95% CI)
Intubation delivery room, n (%)18 (17)37 (36).0020.37 (0.20–0.70)
Total period of mechanical ventilation of intubated infants <72 h of age, median (IQR), d [n]2.5 (1–8.3)[38]4.5 (2–11.5)[52].2
Total period of NCPAP of total group, median (IQR), d2 (0.3–8)2 (0–11).038
Surfactant doses, mean (SD)0.4 (0.8)0.6 (1.0).3
Surfactant >1 dose, n (%)10/103 (10)22/104 (21).020.39 (0.18–0.88)
Mortality, n (%)2 (2)4 (4).4
BPDtotal, n (%)a22 (22a)34 (34a).05
BPDmoderate-severe, n (%)a9 (9a)19 (19a).040.41 (0.18–0.96)
PDA needing treatment, n (%)21 (20)16 (16).4
NEC at least stage 2, n (%)0 (0)1 (1).5
ROP above grade 3, n (%)0 (0)1 (1).5
IVH grade 3 + 4, n (%)7 (7)3 (3).3
Cystic PVL, n (%)2 (2)5 (5).4
  • PDA indicates patent ductus arteriosus; NEC, necrotizing enterocolitis; ROP, retinopathy of prematurity; PVL, periventricular leucomalacia.

  • a Percentage of survivors.